- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Sai Life Sciences Limited — Updates, 05-02-2026: Press Release
05-02-2026 | 11:21 pm
05-02-2026 | 11:21 pm
Sai Life Sciences reported strong Q3FY26: Revenue +27% to ₹556 Cr, EBITDA +54% to ₹191 Cr, PAT +86% to ₹100 Cr. Nine-month results also robust. Company invested ₹405 Cr in capex, advancing AI and technology for future CRDMO growth.
No comments yet. Be the first to comment!